After a two-year diagnostic journey with enormous challenges, Mustafa Shameem was diagnosed with dermatomyositis and antisynthetase syndrome followed by another year of difficult recovery. He wants to make sure all others who follow have an easier journey. He comes to TMA with over fifteen years of experience in management consulting and digital product development from the healthcare to financial industries, along with developing healthcare public policy at a life science think tank. His vision is to transform TMA into the gold standard for rare disease organizations.